http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEAnR0F8HUvKi7ht2utaVjH7Ln95w&url=http://www.acsh.org/many-drugs-cost-a-lot-but-this-one-takes-the-cake/
Tue, 02 Apr 2013 18:02:40 GMT

Corante
Many drugs cost a lot, but this one takes the cake

American Council on Science and Health

In a new op-ed written by ACSH's Dr. Josh Bloom, he discusses a new first-line therapy for multiple sclerosis, Biogen-Idec's Tecfidera. This drug has been shown to significantly reduce the number of patients who relapse as well as reducing lesions in ...

Biogen sets $55K annual price tag on new MS drugBoston Business Journal (blog)

New Copaxone rival costs $55000Globes

Tecfidera Raises The Bar For Biogen IdecSeeking Alpha

Corante -Mideast Time -SBWire (press release)

all 19 news articles »